e-learning
resources
London 2016
Tuesday, 06.09.2016
Techniques and tools in paediatric asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Small airway dysfunction and its role in pediatric asthma control assessment
Olaia Sardon (San Sebastian, Spain), Olaia Sardon, Garazi Azaldegi, Paula Corcuera, Ane Aldasoro, Jose I. Emparanza, Javier Mintegui, Javier Korta, Eduardo G. Pérez-Yarza
Source:
International Congress 2016 – Techniques and tools in paediatric asthma
Session:
Techniques and tools in paediatric asthma
Session type:
Thematic Poster
Number:
4376
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olaia Sardon (San Sebastian, Spain), Olaia Sardon, Garazi Azaldegi, Paula Corcuera, Ane Aldasoro, Jose I. Emparanza, Javier Mintegui, Javier Korta, Eduardo G. Pérez-Yarza. Small airway dysfunction and its role in pediatric asthma control assessment. Eur Respir J 2016; 48: Suppl. 60, 4376
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Effect of spirometry and bronchodilation test in eNO levels
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015
Different patterns of exhaled NO response to acute bronchodilation in asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Validity of the fractional exhaled nitric oxide (FE
NO
) for identification of bronchial hyperresponsiveness in a pulmonary function laboratory
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Exhaled nitric oxide in diagnosis and management of respiratory diseases
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled nitric oxide: A biomarker for chronic lung allograft dysfunction?
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
LATE-BREAKING ABSTRACT: Interaction between airway calibre and exhaled NO: the allergen challenge model.
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Prevalence and relationship of hypomagnesiemia with children bronchial asthma control
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept